These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24295981)

  • 21. Exploring resveratrol dimers as virulence blocking agents - Attenuation of type III secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa.
    Sundin C; Zetterström CE; Vo DD; Brkljača R; Urban S; Elofsson M
    Sci Rep; 2020 Feb; 10(1):2103. PubMed ID: 32034212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Links between type III secretion and extracytoplasmic stress responses in Yersinia.
    Flores-Kim J; Darwin AJ
    Front Cell Infect Microbiol; 2012; 2():125. PubMed ID: 23087910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.
    Zhang Y; Romanov G; Bliska JB
    Infect Immun; 2011 Nov; 79(11):4322-31. PubMed ID: 21844228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LcrQ Coordinates with the YopD-LcrH Complex To Repress
    Fei K; Yan H; Zeng X; Huang S; Tang W; Francis MS; Chen S; Hu Y
    mBio; 2021 Jun; 12(3):e0145721. PubMed ID: 34154409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.
    Lam HN; Lau T; Lentz A; Sherry J; Cabrera-Cortez A; Hug K; Lalljie A; Engel J; Lokey RS; Auerbuch V
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0169020. PubMed ID: 33875435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial adhesion and host cell factors leading to effector protein injection by type III secretion system.
    Bohn E; Sonnabend M; Klein K; Autenrieth IB
    Int J Med Microbiol; 2019 Jul; 309(5):344-350. PubMed ID: 31178419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yersinia pseudotuberculosis YopE prevents uptake by M cells and instigates M cell extrusion in human ileal enteroid-derived monolayers.
    Fasciano AC; Dasanayake GS; Estes MK; Zachos NC; Breault DT; Isberg RR; Tan S; Mecsas J
    Gut Microbes; 2021; 13(1):1988390. PubMed ID: 34793276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium.
    Kimura K; Iwatsuki M; Nagai T; Matsumoto A; Takahashi Y; Shiomi K; Omura S; Abe A
    J Antibiot (Tokyo); 2011 Feb; 64(2):197-203. PubMed ID: 21139624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.
    Garrity-Ryan LK; Kim OK; Balada-Llasat JM; Bartlett VJ; Verma AK; Fisher ML; Castillo C; Songsungthong W; Tanaka SK; Levy SB; Mecsas J; Alekshun MN
    Infect Immun; 2010 Nov; 78(11):4683-90. PubMed ID: 20823209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
    Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
    PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gatekeeper of Yersinia type III secretion is under RNA thermometer control.
    Pienkoß S; Javadi S; Chaoprasid P; Nolte T; Twittenhoff C; Dersch P; Narberhaus F
    PLoS Pathog; 2021 Nov; 17(11):e1009650. PubMed ID: 34767606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A bacterial secreted translocator hijacks riboregulators to control type III secretion in response to host cell contact.
    Kusmierek M; Hoßmann J; Witte R; Opitz W; Vollmer I; Volk M; Heroven AK; Wolf-Watz H; Dersch P
    PLoS Pathog; 2019 Jun; 15(6):e1007813. PubMed ID: 31173606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the structure-activity relationship of a type III secretion system inhibitor, aurodox.
    Kimishima A; Hagimoto D; Honsho M; Watanabe Y; Iwatsuki M; Tsutsumi H; Inahashi Y; Naher K; Sakai K; Kuwae A; Abe A; Asami Y
    Bioorg Med Chem Lett; 2022 Aug; 69():128779. PubMed ID: 35545199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin gallate inhibits the type III secretion system of Gram-negative enteropathogenic bacteria under model conditions.
    Nakasone N; Higa N; Toma C; Ogura Y; Suzuki T; Yamashiro T
    FEMS Microbiol Lett; 2017 Jul; 364(13):. PubMed ID: 28651361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small-molecule inhibitors specifically targeting type III secretion.
    Nordfelth R; Kauppi AM; Norberg HA; Wolf-Watz H; Elofsson M
    Infect Immun; 2005 May; 73(5):3104-14. PubMed ID: 15845518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Yersinia pestis type III secretion system: expression, assembly and role in the evasion of host defenses.
    Plano GV; Schesser K
    Immunol Res; 2013 Dec; 57(1-3):237-45. PubMed ID: 24198067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LcrQ blocks the role of LcrF in regulating the Ysc-Yop type III secretion genes in Yersinia pseudotuberculosis.
    Li L; Yan H; Feng L; Li Y; Lu P; Hu Y; Chen S
    PLoS One; 2014; 9(3):e92243. PubMed ID: 24658611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.